Carranza-Sañudo R

Language: Spanish
References: 20
Page: 32-40
PDF size: 259.06 Kb.

ABSTRACT

Introduction: diabetes mellitus poses a significant challenge in public health, demanding constant concern and an ongoing pursuit of scientific advancements from the medical community. Objective: to assess the impact of depressive symptoms on treatment adherence in patients with type 2 diabetes. Material and methods: a thorough search for published information was conducted in the ScienceDirect, PubMed, SciELO, and Google Scholar databases. Results: initially, 98 articles were found, and 79 were eliminated, leaving 19 studies that met the search criteria. Of the 19 selected articles, 12 provided research findings, and seven were considered for theoretical and conceptual aspects of the study's purpose. Conclusion: this publication is essential for improving our understanding of non-adherence to treatment in diabetic patients. Strategies that incorporate nutritional and psychological support, along with medical endocrinology services, are crucial. Physicians should also focus on the mental and physical well-being of the patient to enhance their quality of life.

REFERENCES

1. Diabetes-OPS/OMS. Organización Panamericana de la Salud. Disponible en: https://www.paho.org/es/temas/diabetes

2. Alidrisi HA, Hammoud MM, Ali HYA, Radhi ME, Alidrisi HA, Hammoud M et al. Type 2 Diabetes Mellitus Patients' Knowledge About Disease Complications and Management Targets for Glucose, Lipids, Blood Pressure, and Body Weight. Cureus. 2024;16 (6): e62766. Disponible en: https://doi.org/10.7759/cureus.62766

3. American Diabetes Association Professional Practice Committee. Introduction and methodology: standards of care in diabetes-2024. Diabetes Care. 2024; 47 (Suppl. 1): S1-S4. doi: 10.2337/dc24-SINT.

4. Yang H, Wu F, Gui M, Cheng Y, Zhang L. The role of medication adherence in the association between depressive symptoms and quality of life in older adults with type 2 diabetes mellitus. BMC Geriatr. 2023; 23 (1): 196.

5. Lai C, Filippetti G, Schifano I, Aceto P, Tomai M, Lai S et al. Psychological, emotional and social impairments are associated with adherence and healthcare spending in type 2 diabetic patients: an observational study. Eur Rev Med Pharmacol Sci. 2019; 23 (2): 749-754.

6. Aronson BD, Sittner KJ, Walls ML. The mediating role of diabetes distress and depressive symptoms in type 2 diabetes medication adherence gender differences. Health Educ Behav. 2020; 47 (3): 474-482.

7. Houssay S, López González E, Luongo ÁM, Milrad S, Linari MA, Houssay S et al. Diabetes tipo 2 ¿En la vida real es posible lograr la meta glucémica? Medicina (Buenos Aires). 2022; 82 (5): 714-721.

8. Vilchez-Cornejo JS, Romani L, Reategui S, Gomez-Rojas E, Silva C. Factores asociados a la realización de actividades de autocuidado en pacientes diabéticos en tres hospitales de Ucayali. Rev Fac Med Hum. 2020; 20 (2). Disponible en: https://inicib.urp.edu.pe/rfmh/vol20/iss2/15

9. Selvakumar D, Sivanandy P, Ingle PV, Theivasigamani K. Relationship between treatment burden, health literacy, and medication adherence in older adults coping with multiple chronic conditions. Medicina (Kaunas). 2023; 59 (8): 1401.

10. León-Jiménez F, Barreto-Pérez D, Altamirano-Cardozo L, Loayza-Enríquez B, Farfán-García J, León-Jiménez F et al. Evaluación del estado de salud en pacientes con diabetes tipo 2 de dos hospitales del norte del Perú. Rev Cuerpo Med HNAAA. 2021; 14 (3): 330-336.

11. Sweileh WM, Abu-Hadeed HM, Al-Jabi SM, Zyoud SH. Prevalence of depression among people with type 2 diabetes mellitus: a cross sectional study in Palestine. BMC Public Health. 2014, 14:163.

12. Lugo-Bautista KS, Medina-Rodríguez JC, Rodríguez-Weber FL, Díaz-Greene EJ, Lugo-Bautista KS, Medina-Rodríguez JC et al. Síntomas depresivos como predictores del grado de adherencia al tratamiento en pacientes con diabetes tipo 2: un estudio transversal. Acta Med. 2023; 21 (1): 28-31.

13. Di Lorenzi R, Garau M, Aída E, Bruno L, Barreneche L, Melone I et al. Asociación entre diabetes y depresión en una población hospitalaria con diabetes mellitus. Rev Urug Med Int. 2023; 8 (1): 13-25.

14. Angelucci-Bastidas L, Rondón JE. Adherencia al tratamiento en diabetes tipo 2: Un modelo de regresión logística. Caracas 2017-2018. Rev médicas UIS. 2021; 34 (2): 29-39. Disponible en: http://www.SciELO.org.co/SciELO.php?script=sci_arttext&pid=S0121-03192021000200029&lang=es

15. Vázquez-Díaz ME, Flores-Bautista P, Mata-Tomás EA, Ríos-Terrazas R. Proceso de duelo y adherencia al tratamiento en diabetes tipo 2. Rev Mex Med Fam. 2023; 10: 81-88 Disponible en: http://www.revmexmedicinafamiliar.org/abstract.php?id=132

16. González-Heredia T, González-Ramírez LP, Hernández-Corona DM, Maciel-Hernández EA. Anxious depression in patients with Type 2 Diabetes Mellitus and its relationship with medication adherence and glycemic control. Glob Public Health. 2021; 16 (3): 460-468.

17. Abdullah MFILB, Sidi H, Ravindran A, Gosse PJ, Kaunismaa ES, Mainland RL et al. How much do we know about the biopsychosocial predictors of glycaemic control? Age and clinical factors predict glycaemic control, but psychological factors do not. J Diabetes Res. 2020; 2020: 2654208.

18. Sánchez-Cruz JF, Hipólito-Lóenzo A, Mugártegui-Sánchez SG, Yáñez-González RM. Estrés y depresión asociados a la no adherencia al tratamiento en pacientes con diabetes mellitus tipo 2. Aten Fam. 2016; 23 (2): 43-47.

19. Rondón-Bernard JE, Angelucci-Bastidas L, Rondón-Bernard JE, Angelucci-Bastidas L. Relación entre depresión y adherencia al tratamiento en diabetes tipo 2, considerando la red de apoyo social, las estrategias de afrontamiento y el sexo. Rev Costarric Psic. 2021; 40 (2): 215-242.

20. Osborn CY, Egede LE. The relationship between depressive symptoms and medication non-adherence in type 2 diabetes: the role of social support. Gen Hosp Psychiatry. 2012; 34 (3): 249-253.